Apeiron Investment Group Ltd. 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-02 5:00 pm Sale | 2023-06-01 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 0 0.000% | -172,083 (Position Closed) | Filing |
| 2023-05-23 4:50 pm Unchanged | 2023-05-23 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 172,083 11.100% | 0 (Unchanged) | Filing |
| 2023-03-09 5:15 pm Purchase | 2023-03-09 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 172,083 11.200% | 110 (+0.06%) | Filing |
| 2022-11-21 06:15 am Unchanged | 2022-11-21 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 171,973 11.200% | 0 (Unchanged) | Filing |
| 2022-11-02 11:58 am Unchanged | 2022-11-02 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 171,973 11.200% | 0 (Unchanged) | Filing |
| 2022-07-19 5:30 pm Purchase | 2022-07-14 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 171,973 11.200% | 10,500 (+6.50%) | Filing |
| 2022-02-10 5:15 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 161,473 10.600% | 28,881 (+21.78%) | Filing |
| 2021-02-18 4:15 pm Purchase | 2021-02-08 | 13G | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 132,592 8.700% | 132,592 (New Position) | Filing |